ATG5 and nasopharyngeal carcinoma: Our study showed that, compared with those in PTX-resistant NPC patients, the expression levels of LC3-II and ATG5 were significantly higher while the expression levels of SQSTM1 were significantly lower in PTX-sensitive NPC patients.